Anticancer drugs (Doxorubicin, Methotrexate, Daunorubicin, etc.,) shows excellent activity on killing cancer cells, equal amount of cytotoxicity is also observed in healthy cells as well due to its non-specificity. Modern drug delivery systems proved that the stimuli sensitive peptide-drug conjugate as an alternate method to overcome this problem of severe side effects caused by the anticancer agents. Therefore, our research group designed a novel hypothesize that, a combination of pH and thermo sensitive peptide-drug conjugate, a prodrug concept could be the lead method for the treatment of modern chemotherapy to solid tumors. This dual-sensitive peptide-drug conjugate combination strategy will develop a pioneer drug carrier in the field of drug delivery systems (DDS).
This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Akimoto J, Nakayama M, Okano T (2014) Temperature-responsive polymeric micelles for optimizing drug targeting to solid tumors. J Control Release 193:2–8
Ali M, Yang F, Jansen J (2017) Smart drug delivery systems for tissue engineering, chapter 18, smart materials for tissue engineering: applications. Royal Society of Chemistry, London
Cho H, Kwon GS (2014) Thermosensitive poly-(d, l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d, l-lactide-co-glycolide) hydrogels for multi-drug delivery. J Drug Target 22:669–677
Chung JE, Yokoyama M, Yamato M, Aoyagi T, Sakurai Y, Okano T (1999) Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly (butylmethacrylate). J Control Release 62:115–127
Dash M (2016) Protein-based stimuli responsive materials for tissue engineering, chapter 3, smart materials for tissue engineering: fundamental principles. Royal Society of Chemistry, London
Dreher MR, Raucher D, Balu N, Colvin OM, Ludeman SM, Chilkoti A (2003) Evaluation of an elastin-like polypeptide-doxorubicin conjugate for cancer therapy. J Control Release 91:31–43
Gavhane YN (2013) Solid tumors: facts, challenges and solutions. Int J Pharma Sci Res 2(1):1–12
Guo L (2016) Conducting polymers as smart materials for tissue engineering, chapter 9, smart materials for tissue engineering: fundamental principles. Royal Society of Chemistry, London
Harris JM, Chess RB (2003) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2:214–221
Hu R, Zheng H, Cao J, Davoudi Z, Wang Q (2017a) Self-assembled hyaluronic acid nanoparticles for pH-sensitive release of doxorubicin: synthesis and in vitro characterization. J Biomed Nanotechnol 13(9):1058–1068
Hu R, Zheng H, Cao J, Davoudi Z, Wang Q (2017b) Synthesis and in vitro characterization of carboxymethyl chitosan-CBA-doxorubicin conjugate nanoparticles as pH-sensitive drug delivery systems. J Biomed Nanotechnol 13(9):1097–1105
Knop K, Hoogenboom R, Fischer D, Schubert US (2010) Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed 49:6288–6308
Lammers T, Kiessling F, Hennink WE, Strom G (2012) Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release 161:175–187
Li L, Wang H (2016) Self-assembled biomaterials for tissue engineering, chapter 5, smart materials for tissue engineering: fundamental principles. Royal Society of Chemistry, London
Meyer DE, Shin BC, Kong GA, Dewhirst MW, Chilkoti A (2001) Drug targeting using thermally responsive polymers and local hyperthermia. J Control Release 74:213–224
Parveen S, Arjmand F, Tabassum S (2019) Clinical developments of antitumor polymer therapeutics. RSC Adv 9:24699
Peng H, Liu X, Wang G, Li M, Bratlie KM, Cochran EW, Wang Q (2015) Polymeric multifunctional nanomaterials for theranostics. J Mater Chem B 3:6856–6870. https://doi.org/10.1039/C5TB00617A
Qi Y, Shi E, Peroutka-Bigus N, Bellaire B, Wannemuehler M, Jergens A, Barrett T, Wu Y, Wang Q (2018) Ex vivo study of telluride nanowires in Minigut. J Biomed Nanotechnol 14:978–986. https://doi.org/10.1166/jbn.2018.2578
Qiao Y, Qin G, Yu L (2013) The triblock copolymers hydrogel through intracameral injection may be a new potential ophthalmic drug delivery with antiscaring drugs after glaucoma filtration surgery. Med Hyp 80:23–25
Qu Y, Wei Wei X, Qian Z (2016) Thermosensitive biomaterials in tissue engineering, chapter 15, smart materials for tissue engineering: fundamental principles. Royal Society of Chemistry, London
Rahman M, Diana Giol E, Cama G, Van Vlierberghe S, Dubruel P (2016) Stimuli-responsive hydrogels for tissue engineering, chapter 4, smart materials for tissue engineering: fundamental principles. Royal Society of Chemistry, London
Shi Z, Gao X, Wajid Ullah M, Li S, Wang Q (2016) Electro conductive natural polymer-based hydrogels. Biomaterials 111:40–54
Ulbricht J, Jordan R, Luxenhofer R (2014) On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s. Biomaterials 35:4848–4861
Yang L, Wang B, Qiao W, Liu P (2009) A novel combination chemotherapy integrating with intratumoral chemotherapy. Med Hyp 73:334–335
Zhang C, Pan D, Luo K, Li N, Guo C, Zheng X, Gu Z (2014) Dendrimer-doxorubicin conjugate as enzyme-sensitive and polymeric nanoscale drug delivery vehicle for ovarian cancer therapy. Polym Chem 5:5227–5235
Zhang X, Zhang H, Yin L, Hu R, Qiu T, Yin Y, Xiong X, Zheng H, Wang Q (2016) A pH-sensitive nanosystem based on carboxymethyl chitosan for tumor-targeted delivery of daunorubicin. J Biomed Nanotechnol 12(8):1688–1698
Zheng H, Yin L, Zhang X, Zhang H, Hu R, Yin Y, Qiu T, Xiong X, Wang Q (2016) Redox sensitive shell and core crosslinked hyaluronic acid nanocarriers for tumor-targeted drug delivery. J Biomed Nanotechnol 12:1641–1653. https://doi.org/10.1166/jbn.2016.2279
Zhu H, Cao Z (2017) Smart biomaterials for cell encapsulation, chapter 6, smart materials for tissue engineering: applications. Royal Society of Chemistry, London
We would like to thank the Department of Biotechnology, Government of India for financial support (Project Approval No: BT/PR16289/NER/95/113/2015).
Department of Biotechnology, Government of India (Project Approval No: BT/PR16289/NER/95/113/2015).
Conflict of interest
The authors declare no conflict of interest for this article.
This article does not contain any studies with human or animal subjects.
This article does not contain any studies with human or animal subjects, so that there is no informed consent to be attached.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Santhosh, S.B., Chandrasekar, M.J.N. Isoelectric Point Based Dual Sensitive Peptide-Drug Conjugate Prodrug to Target Solid Tumors. Int J Pept Res Ther (2020). https://doi.org/10.1007/s10989-020-10022-w
- Anticancer drug
- Peptide-drug conjugate